Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imre Noth

Showing results (71-80 of 211) with videos related to

Pageof 22
Sort By:
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Age-dependent Genetic Risk in Pulmonary Fibrosis Patients and RelativesDavid Zhang, Chad A Newton, Imre Noth, et al.
American Journal of Respiratory and Critical Care Medicine|April 21, 2022
Toll-Interacting Protein and Altered Lung Microbiota in Idiopathic Pulmonary FibrosisJay H Lipinski, John R Erb-Downward, Gary B Huffnagle, et al.
Frontiers in Immunology|December 10, 2016
Skewed Lung CCR4 to CCR6 CD4<sup>+</sup> T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary FunctionAyodeji Adegunsoye, Cara L Hrusch, Catherine A Bonham, et al.
AJR. American Journal of Roentgenology|November 16, 2017
CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary FibrosisJonathan H Chung, Christian W Cox, Steven M Montner, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Sex-related transcriptomic differences in idiopathic pulmonary fibrosisAravind A Menon, Matthew Moll, Janelle V Pugashetti, et al.
The Lancet. Respiratory Medicine|July 22, 2019
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled studyToby M Maher, Susanne Stowasser, Yasuhiko Nishioka, et al.
The European Respiratory Journal|October 30, 2020
Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitisAyodeji Adegunsoye, Julie Morisset, Chad A Newton, et al.
Frontiers in Immunology|January 31, 2024
High-dimensional comparison of monocytes and T cells in post-COVID and idiopathic pulmonary fibrosisGrace C Bingham, Lyndsey M Muehling, Chaofan Li, et al.
Respiratory Medicine|November 28, 2016
Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung diseaseJustin M Oldham, Cathryn Lee, Eleanor Valenzi, et al.
Respiratory Medicine: X|May 27, 2020
T cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survivalCatherine A Bonham, Cara L Hrusch, Kelly M Blaine, et al.
Pageof 22

Showing results (71-80 of 211) with videos related to

Sort By:
Pageof 22
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Age-dependent Genetic Risk in Pulmonary Fibrosis Patients and RelativesDavid Zhang, Chad A Newton, Imre Noth, et al.
American Journal of Respiratory and Critical Care Medicine|April 21, 2022
Toll-Interacting Protein and Altered Lung Microbiota in Idiopathic Pulmonary FibrosisJay H Lipinski, John R Erb-Downward, Gary B Huffnagle, et al.
Frontiers in Immunology|December 10, 2016
Skewed Lung CCR4 to CCR6 CD4<sup>+</sup> T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary FunctionAyodeji Adegunsoye, Cara L Hrusch, Catherine A Bonham, et al.
AJR. American Journal of Roentgenology|November 16, 2017
CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary FibrosisJonathan H Chung, Christian W Cox, Steven M Montner, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Sex-related transcriptomic differences in idiopathic pulmonary fibrosisAravind A Menon, Matthew Moll, Janelle V Pugashetti, et al.
The Lancet. Respiratory Medicine|July 22, 2019
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled studyToby M Maher, Susanne Stowasser, Yasuhiko Nishioka, et al.
The European Respiratory Journal|October 30, 2020
Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitisAyodeji Adegunsoye, Julie Morisset, Chad A Newton, et al.
Frontiers in Immunology|January 31, 2024
High-dimensional comparison of monocytes and T cells in post-COVID and idiopathic pulmonary fibrosisGrace C Bingham, Lyndsey M Muehling, Chaofan Li, et al.
Respiratory Medicine|November 28, 2016
Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung diseaseJustin M Oldham, Cathryn Lee, Eleanor Valenzi, et al.
Respiratory Medicine: X|May 27, 2020
T cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survivalCatherine A Bonham, Cara L Hrusch, Kelly M Blaine, et al.
Pageof 22